Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve 1. The Audited Standalone and ....
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies has informed the stock exchanges that its Board of Directors will meet on Thursday, 22nd May 2025. The main agenda items are: (1) to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and full year ended 31st March 2025, and (2) to consider recommending a final dividend, if any, for FY25. The trading window for insiders is already closed and will remain shut until 24th May 2025 (48 hours after results are declared). This is a routine regulatory intimation under SEBI's Listing Regulations and does not contain any actual financial numbers.
No immediate impact on the stock. Investors should watch 22nd May for FY25 audited numbers and any dividend announcement, which could be positive catalysts if results are strong or a healthy dividend is declared.